JP2013502225A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013502225A5 JP2013502225A5 JP2012525730A JP2012525730A JP2013502225A5 JP 2013502225 A5 JP2013502225 A5 JP 2013502225A5 JP 2012525730 A JP2012525730 A JP 2012525730A JP 2012525730 A JP2012525730 A JP 2012525730A JP 2013502225 A5 JP2013502225 A5 JP 2013502225A5
- Authority
- JP
- Japan
- Prior art keywords
- polynucleotide
- seq
- sequence identity
- sequence shown
- apmv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091033319 polynucleotide Proteins 0.000 claims 106
- 239000002157 polynucleotide Substances 0.000 claims 106
- 102000040430 polynucleotide Human genes 0.000 claims 106
- 241000724287 Apple mosaic virus Species 0.000 claims 22
- 230000000295 complement effect Effects 0.000 claims 16
- 229920001184 polypeptide Polymers 0.000 claims 14
- 108090000765 processed proteins & peptides Proteins 0.000 claims 14
- 102000004196 processed proteins & peptides Human genes 0.000 claims 14
- 239000000427 antigen Substances 0.000 claims 9
- 108091007433 antigens Proteins 0.000 claims 9
- 102000036639 antigens Human genes 0.000 claims 9
- 241001465754 Metazoa Species 0.000 claims 8
- 238000000034 method Methods 0.000 claims 8
- 239000013603 viral vector Substances 0.000 claims 7
- 108700026244 Open Reading Frames Proteins 0.000 claims 6
- 239000013613 expression plasmid Substances 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 229960005486 vaccine Drugs 0.000 claims 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 108091023045 Untranslated Region Proteins 0.000 claims 4
- 230000028993 immune response Effects 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 239000013612 plasmid Substances 0.000 claims 4
- 238000013518 transcription Methods 0.000 claims 4
- 230000035897 transcription Effects 0.000 claims 4
- 241001493169 Avian avulavirus 2 Species 0.000 claims 2
- 241001135673 Avian avulavirus 4 Species 0.000 claims 2
- 241000029382 Avian avulavirus 6 Species 0.000 claims 2
- 241000283690 Bos taurus Species 0.000 claims 2
- 241000283073 Equus caballus Species 0.000 claims 2
- 241000282326 Felis catus Species 0.000 claims 2
- 241000282414 Homo sapiens Species 0.000 claims 2
- 108091029795 Intergenic region Proteins 0.000 claims 2
- 241001494479 Pecora Species 0.000 claims 2
- 241000009328 Perro Species 0.000 claims 2
- 241000282898 Sus scrofa Species 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 230000002458 infectious effect Effects 0.000 claims 2
- 244000052769 pathogen Species 0.000 claims 2
- 230000001717 pathogenic effect Effects 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 238000011144 upstream manufacturing Methods 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23591209P | 2009-08-21 | 2009-08-21 | |
| US61/235,912 | 2009-08-21 | ||
| PCT/US2010/046179 WO2011022656A2 (en) | 2009-08-21 | 2010-08-20 | Recombinant avian paramyxovirus vaccine and method for making and using thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015246684A Division JP2016041079A (ja) | 2009-08-21 | 2015-12-17 | 組換えトリパラミクソウイルスワクチン並びに前記の製造および使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013502225A JP2013502225A (ja) | 2013-01-24 |
| JP2013502225A5 true JP2013502225A5 (enExample) | 2013-10-03 |
| JP6221167B2 JP6221167B2 (ja) | 2017-11-01 |
Family
ID=43027613
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012525730A Active JP6221167B2 (ja) | 2009-08-21 | 2010-08-20 | 組換えトリパラミクソウイルスワクチン並びに前記の製造および使用方法 |
| JP2015246684A Pending JP2016041079A (ja) | 2009-08-21 | 2015-12-17 | 組換えトリパラミクソウイルスワクチン並びに前記の製造および使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015246684A Pending JP2016041079A (ja) | 2009-08-21 | 2015-12-17 | 組換えトリパラミクソウイルスワクチン並びに前記の製造および使用方法 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8486418B2 (enExample) |
| EP (2) | EP3210622B1 (enExample) |
| JP (2) | JP6221167B2 (enExample) |
| KR (1) | KR101745029B1 (enExample) |
| CN (2) | CN105331633A (enExample) |
| BR (1) | BR112012003837B8 (enExample) |
| CA (1) | CA2771540C (enExample) |
| CL (2) | CL2012000447A1 (enExample) |
| CO (1) | CO6511253A2 (enExample) |
| ES (2) | ES2867457T3 (enExample) |
| HU (2) | HUE053237T2 (enExample) |
| MX (1) | MX2012002114A (enExample) |
| PL (2) | PL3210622T3 (enExample) |
| PT (2) | PT3210622T (enExample) |
| RU (2) | RU2592544C2 (enExample) |
| SG (2) | SG178523A1 (enExample) |
| UA (1) | UA110328C2 (enExample) |
| WO (1) | WO2011022656A2 (enExample) |
| ZA (1) | ZA201201245B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD4655C1 (ro) | 2013-03-14 | 2020-06-30 | Icahn School Of Medicine At Mount Sinai | Virusurile bolii de Newcastle şi utilizarea acestora |
| US20140341950A1 (en) * | 2013-05-15 | 2014-11-20 | University Of Georgia Research Foundation, Inc. | Recombinant avian paramyxovirus vaccine and method for making and using thereof |
| US20170000832A1 (en) | 2014-02-27 | 2017-01-05 | Viralytics Limited | Combination method for treatment of cancer |
| CN104195116B (zh) * | 2014-08-13 | 2018-03-06 | 吉林大学 | 一种表达鹅细小病毒vp3基因的重组新城疫病毒及其构建方法 |
| CA2956291A1 (en) * | 2014-08-22 | 2016-02-25 | Investigacion Aplicada, S.A. De C.V. | Emulsified vaccine to obtain formulations of concentrated igy immunoglobulins; processes and uses for the same |
| US10010499B2 (en) | 2014-11-03 | 2018-07-03 | Merial Inc. | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus |
| JOP20190256A1 (ar) | 2017-05-12 | 2019-10-28 | Icahn School Med Mount Sinai | فيروسات داء نيوكاسل واستخداماتها |
| CN107254450A (zh) * | 2017-07-20 | 2017-10-17 | 扬州大学 | 克服鸡新城疫母源抗体影响的嵌合新城疫病毒疫苗载体候选株及构建方法 |
| WO2019036682A1 (en) | 2017-08-18 | 2019-02-21 | Modernatx, Inc. | RNA VARIANTS POLYMERASE |
| CN108315486A (zh) * | 2018-04-11 | 2018-07-24 | 张薇 | 一种用于检测罗湖病毒的环介导等温扩增引物组及试剂盒 |
| US20200297787A1 (en) * | 2018-07-13 | 2020-09-24 | Icahn School Of Medicine At Mount Sinai | Apmv and uses thereof for the treatment of cancer |
| US12391957B2 (en) | 2018-08-17 | 2025-08-19 | Icahn School Of Medicine At Mount Sinai | Recombinant Newcastle disease viruses and uses thereof for the prevention of RSV disease or human metapneumovirus disease |
| JP2022521094A (ja) | 2019-02-20 | 2022-04-05 | モデルナティエックス インコーポレイテッド | 共転写キャッピング用ｒｎａポリメラーゼバリアント |
| CN114390946A (zh) | 2019-11-13 | 2022-04-22 | 株式会社Ihi | 将填充部件插入反应装置中的夹具 |
| CN112111467B (zh) * | 2020-09-27 | 2021-06-22 | 湖北省农业科学院畜牧兽医研究所 | 一种基因vii型新城疫标记疫苗株及其制备方法与应用 |
| CN116068196A (zh) * | 2022-10-26 | 2023-05-05 | 新疆农业大学 | 一种检测禽副黏病毒4型血清抗体的elisa方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
| US5174993A (en) | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
| US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
| US4769330A (en) | 1981-12-24 | 1988-09-06 | Health Research, Incorporated | Modified vaccinia virus and methods for making and using the same |
| US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
| US4708871A (en) | 1983-03-08 | 1987-11-24 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
| AU672359B2 (en) | 1991-03-07 | 1996-10-03 | Virogenetics Corporation | Genetically engineered vaccine strain |
| ATE292980T1 (de) | 1996-10-11 | 2005-04-15 | Univ California | Immunostimulierende oligonucleotidekonjugate |
| FR2778858B1 (fr) | 1998-05-20 | 2000-06-16 | Oreal | Emulsion e/h/e stable et son utilisation comme composition cosmetique et/ou dermatologique |
| EP0974660A1 (en) * | 1998-06-19 | 2000-01-26 | Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) | Newcastle disease virus infectious clones, vaccines and diagnostic assays |
| FR2801607B1 (fr) | 1999-11-26 | 2001-12-28 | Merial Sas | Pneumovirus du canard et vaccins correspondants |
| RU2162341C1 (ru) * | 2000-03-06 | 2001-01-27 | Открытое акционерное общество "ВЫМПЕЛ КОМПЛЕКС" | Сухая живая вакцина против ньюкаслской болезни и способ ее получения |
| JP4791651B2 (ja) * | 2000-05-18 | 2011-10-12 | 株式会社ディナベック研究所 | 外来遺伝子導入用パラミクソウイルスベクター |
| MXPA03003700A (es) * | 2000-11-02 | 2004-05-04 | Akzo Nobel Nv | Mutante de nucleoproteina recombinante de virus de enfermedad de newcastle en la forma de una vacuna marcadora. |
| JP2006528647A (ja) | 2003-07-24 | 2006-12-21 | メリアル リミテッド | 新規ワクチン製剤 |
| AU2007224430A1 (en) * | 2006-03-15 | 2007-09-20 | Intervet International B.V. | Recombinant Newcastle disease virus expressing H5 hemagglutinin of avian influenza virus |
| EP1834651A1 (en) * | 2006-03-15 | 2007-09-19 | Universiteit Gent | Compositions and methods for veterinary vaccination |
| CN101421294A (zh) * | 2006-03-15 | 2009-04-29 | 英特威国际有限公司 | 表达禽流感病毒的h5血凝素的重组新城疫病毒 |
| US20090175826A1 (en) * | 2006-06-05 | 2009-07-09 | Elankumaran Subbiah | Genetically-engineered newcastle disease virus as an oncolytic agent, and methods of using same |
| US20090208495A1 (en) | 2008-02-14 | 2009-08-20 | Bayer Schering Pharma Ag | Anti-tumor effective paramyxovirus |
| JP5797636B2 (ja) * | 2009-04-03 | 2015-10-21 | メリアル リミテッド | ニューカッスル病ウイルスをベクターとするトリワクチン |
-
2010
- 2010-08-20 UA UAA201203242A patent/UA110328C2/ru unknown
- 2010-08-20 PL PL16204538T patent/PL3210622T3/pl unknown
- 2010-08-20 KR KR1020127007373A patent/KR101745029B1/ko active Active
- 2010-08-20 RU RU2012110576/10A patent/RU2592544C2/ru active
- 2010-08-20 SG SG2012011912A patent/SG178523A1/en unknown
- 2010-08-20 SG SG10201405123WA patent/SG10201405123WA/en unknown
- 2010-08-20 EP EP16204538.9A patent/EP3210622B1/en active Active
- 2010-08-20 PL PL10747133T patent/PL2467158T3/pl unknown
- 2010-08-20 HU HUE16204538A patent/HUE053237T2/hu unknown
- 2010-08-20 EP EP10747133.6A patent/EP2467158B1/en active Active
- 2010-08-20 CN CN201510564915.XA patent/CN105331633A/zh active Pending
- 2010-08-20 CA CA2771540A patent/CA2771540C/en active Active
- 2010-08-20 US US12/860,589 patent/US8486418B2/en active Active
- 2010-08-20 JP JP2012525730A patent/JP6221167B2/ja active Active
- 2010-08-20 PT PT162045389T patent/PT3210622T/pt unknown
- 2010-08-20 MX MX2012002114A patent/MX2012002114A/es active IP Right Grant
- 2010-08-20 ES ES16204538T patent/ES2867457T3/es active Active
- 2010-08-20 WO PCT/US2010/046179 patent/WO2011022656A2/en not_active Ceased
- 2010-08-20 CN CN201080045564.7A patent/CN102573901B/zh active Active
- 2010-08-20 BR BR112012003837A patent/BR112012003837B8/pt active Search and Examination
- 2010-08-20 RU RU2016112465A patent/RU2016112465A/ru not_active Application Discontinuation
- 2010-08-20 HU HUE10747133A patent/HUE033886T2/en unknown
- 2010-08-20 ES ES10747133T patent/ES2622087T3/es active Active
- 2010-08-20 PT PT107471336T patent/PT2467158T/pt unknown
-
2012
- 2012-02-20 ZA ZA2012/01245A patent/ZA201201245B/en unknown
- 2012-02-21 CL CL2012000447A patent/CL2012000447A1/es unknown
- 2012-03-20 CO CO12046741A patent/CO6511253A2/es unknown
-
2015
- 2015-08-04 CL CL2015002175A patent/CL2015002175A1/es unknown
- 2015-12-17 JP JP2015246684A patent/JP2016041079A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013502225A5 (enExample) | ||
| Kamel et al. | Foot-and-mouth disease vaccines: recent updates and future perspectives | |
| RU2012110576A (ru) | Рекомбинантная вакцина на основе парамиксовирусов птиц и способ её приготовления и применения | |
| Bello et al. | Exploring the prospects of engineered Newcastle disease virus in modern vaccinology | |
| JP2018520997A5 (enExample) | ||
| JP2021184761A (ja) | ウイルス様粒子からの感染性インフルエンザウイルスの生成 | |
| JP2014516536A5 (enExample) | ||
| HU229101B1 (en) | Dna transfection system for the generation of infectious influenza virus | |
| JP2013515747A5 (enExample) | ||
| JP2017522907A5 (enExample) | ||
| Klem et al. | Occurrence and phylogenetic analysis of bovine respiratory syncytial virus in outbreaks of respiratory disease in Norway | |
| JP2016513115A5 (enExample) | ||
| Rouxel et al. | Attenuated infectious hematopoietic necrosis virus with rearranged gene order as potential vaccine | |
| JP2019523648A5 (enExample) | ||
| Li et al. | Development of the full-length cDNA clones of two porcine epidemic diarrhea disease virus isolates with different virulence | |
| JP6599316B2 (ja) | 改善されたウイルス産生のためのトリ細胞 | |
| CN106459997A (zh) | 用于疫苗应用的高效价病毒样囊泡的进化 | |
| CN103627718B (zh) | 表达ibv s1和n双抗原蛋白重组质粒及其构建方法和应用 | |
| RU2018122755A (ru) | Слитые белки fmdv-e2 и их применение | |
| JP2011504367A5 (enExample) | ||
| Kim et al. | Generation of G gene-deleted viral hemorrhagic septicemia virus (VHSV) and evaluation of its vaccine potential in olive flounder (Paralichthys olivaceus) | |
| Rodriguez Pulido et al. | Attenuated foot-and-mouth disease virus RNA carrying a deletion in the 3′ noncoding region can elicit immunity in swine | |
| Zimmer | RNA replicons-a new approach for influenza virus immunoprophylaxis | |
| EP1736539A1 (en) | Attenuated SARS-CoV vaccines | |
| Wang et al. | Rapid development of an effective newcastle disease virus vaccine candidate by attenuation of a genotype VII velogenic isolate using a simple infectious cloning system |